Mechanism of Stress-induced Translocation of the Serotonin Transporter
Mechanism of Stress-induced Translocation of the Serotonin Transporter
批准号:
8651756
负责人:
Charles Chavkin
金额:
$23.18万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-04-15 至 2016-03-31
关键词:
AffectAgonistAmericanAnimal ModelBehaviorBehavioralBrainCarrier ProteinsCell membraneCell surfaceCodeCorpus striatum structureCytoplasmic TailDorsalDynorphinsEndogenous depressionEngineeringExposure toGene DeletionGenesGeneticGoalsHumanHuman GenomeIn VitroIndividualIndividual DifferencesInjection of therapeutic agentKineticsMAP Kinase GeneMAPK14 geneMeasuresMental DepressionMolecularMusMutateMutationNerveNeuronsOpioid ReceptorPersonsPopulationProtein translocationQuality of lifeRecoveryRegulationResearch DesignRiskRisk FactorsSeriesSerotoninSiteSite-Directed MutagenesisStressStress-Induced ProteinSwimmingSynaptosomesTestingVariantVentral StriatumViralbasebiological adaptation to stressdisorder riskdopamine transporterdorsal raphe nucleusdysphoriagenome sequencingimprovedinsightneurochemistrynovelparticlepublic health relevanceresearch studyresponseserotonin transportersocialstress resiliencetherapy design
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Repeated stress exposure produces a dysphoria-like response in mice that manifests behaviorally as stress-induced immobility, aversion and social avoidance. In a series of recent studies, we found that exposure to different forms of sustained stress activates a cascade of neurochemical responses in brain involving CRF activation of dynorphin release, dynorphin activation of kappa opioid receptors, kappa stimulation of p38alpha MAPK, and subsequent translocation of the serotonin transporter (SERT) from an endosomal compartment to the plasma membrane. Conditional gene deletion approaches and neurochemical studies revealed that the stress-induced aversion response specifically required the dynorphin/Kappa/p38alpha MAPK/SERT in the dorsal raphe serotonergic nerve terminals innervating the ventral striatum; disruption of any one of these components genetically or pharmacologically blocked the stress-induced dysphoric response and conferred stress-resilience in these animal models. Because stress-vulnerability is a known risk factor for clinical
depression in humans, the proposed studies are designed to further characterize the mechanisms responsible for SERT translocation in the serotonergic nerve terminals. Specifically, we propose to express the human-SERT gene by local injection of a lentiviral construct containing the normal hSERT coding sequence into dorsal raphe neurons of SERT(-/-) mice. We previously showed that this restores SERT functionality and stress-vulnerability in the mice. In aim 1, we would alter the hSERT coding region in the lenti-hSERT by a systematic site-directed mutagenesis approach to define the structural features of SERT necessary for stress-induced translocation. Natural variants of hSERT have been identified in the human population by genome sequencing, and some of these variants have been described as conferring disease risk to the affected individuals. In aim 2, we would engineer lenti-hSERT to express these natural variants, then determine the effects of the resulting structural changes on the stress-response in mice. SERT(-/-) mice expressing different forms of the lenti-hSERT would be assessed 1) behaviorally for stress-induced aversion responses, 2) neurochemically for stress-induced translocation of SERT protein to plasma membrane of synaptosomes isolated from ventral striata, and 3) biophysically using rotating disk electrovoltammetry to define the effects f stress on serotonin transport kinetics. The proposed studies would better define how stress-induced changes in serotonin transport in the ventral striatum might control the risk of depression-like behaviors in mice, and the proposed analysis of the natural human variants of SERT might help describe a possible genetic basis for individual differences in stress-resilience.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Molecular Genetics Resource Core
-
批准号:10152570
-
项目类别:
-
资助金额:$44.71万
-
财政年份:2019
-
负责人:Charles Chavkin
-
依托单位:
Molecular Genetics Resource Core
-
批准号:10611875
-
项目类别:
-
资助金额:$41.91万
-
财政年份:2019
-
负责人:Charles Chavkin
-
依托单位:
Molecular Genetics Resource Core
-
批准号:10394249
-
项目类别:
-
资助金额:$44.71万
-
财政年份:2019
-
负责人:Charles Chavkin
-
依托单位:
Pilot Project Core
-
批准号:10394250
-
项目类别:
-
资助金额:$13.57万
-
财政年份:2019
-
负责人:Charles Chavkin
-
依托单位:
Admin Core
-
批准号:10152568
-
项目类别:
-
资助金额:$25.06万
-
财政年份:2019
-
负责人:Charles Chavkin
-
依托单位:
University of Washington Center of Excellence in Opioid Addiction Research
-
批准号:10611870
-
项目类别:
-
资助金额:$132.76万
-
财政年份:2019
-
负责人:Charles Chavkin
-
依托单位:
University of Washington Center of Excellence in Opioid Addiction Research
-
批准号:10152567
-
项目类别:
-
资助金额:$132.39万
-
财政年份:2019
-
负责人:Charles Chavkin
-
依托单位:
University of Washington Center of Excellence in Opioid Addiction Research
-
批准号:10394246
-
项目类别:
-
资助金额:$132.49万
-
财政年份:2019
-
负责人:Charles Chavkin
-
依托单位:
Admin Core
-
批准号:10611871
-
项目类别:
-
资助金额:$25.25万
-
财政年份:2019
-
负责人:Charles Chavkin
-
依托单位:
Imaging and Neural Circuits Core
-
批准号:10394248
-
项目类别:
-
资助金额:$49.05万
-
财政年份:2019
-
负责人:Charles Chavkin
-
依托单位:
Imaging and Neural Circuits Core
-
批准号:10152569
-
项目类别:
-
资助金额:$49.05万
-
财政年份:2019
-
负责人:Charles Chavkin
-
依托单位:
University of Washington Center of Excellence in Opioid Addiction Research
-
批准号:9791661
-
项目类别:
-
资助金额:$127.64万
-
财政年份:2019
-
负责人:Charles Chavkin
-
依托单位:
Pilot Project Core
-
批准号:10152571
-
项目类别:
-
资助金额:$13.57万
-
财政年份:2019
-
负责人:Charles Chavkin
-
依托单位:
Admin Core
-
批准号:10394247
-
项目类别:
-
资助金额:$25.15万
-
财政年份:2019
-
负责人:Charles Chavkin
-
依托单位:
Pilot Project Core
-
批准号:10611877
-
项目类别:
-
资助金额:$13.57万
-
财政年份:2019
-
负责人:Charles Chavkin
-
依托单位:
Imaging and Neural Circuits Core
-
批准号:10611873
-
项目类别:
-
资助金额:$52.03万
-
财政年份:2019
-
负责人:Charles Chavkin
-
依托单位:
Training in the Molecular Pharmacology of Abused Drugs
-
批准号:9388593
-
项目类别:
-
资助金额:$0.72万
-
财政年份:2016
-
负责人:Charles Chavkin
-
依托单位:
Stress Mechanisms Increasing Risk of Mood-Disorders
-
批准号:9038450
-
项目类别:
-
资助金额:$152.67万
-
财政年份:2015
-
负责人:Charles Chavkin
-
依托单位:
p38 MAPK Mechanisms of Kappa Opioid-Induced Aversion
-
批准号:8786070
-
项目类别:
-
资助金额:$30.93万
-
财政年份:2011
-
负责人:Charles Chavkin
-
依托单位:
p38 MAPK Mechanisms of Kappa Opioid-Induced Aversion
-
批准号:8587473
-
项目类别:
-
资助金额:$31.46万
-
财政年份:2011
-
负责人:Charles Chavkin
-
依托单位:
国内基金
海外基金
Agonist-GPR119-Gs复合物的结构生物学研究
-
批准号:32000851
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:乔安娜
-
依托单位: